⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Biokine Therapeutics just got measured.
5/10 means Biokine Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Biokine Therapeutics
Targeting Migration, Survival and Immune-response Pathways In cancer The Biokine Story Biokine Therapeutics is a private biopharmaceutical company founded in 2000. Biokine lead product BKT140/BL8040, is a high affinity, long-acting CXCR4 receptor inhibitor that already passed successful Phase III for Stem Cell Mobilization and Phase I/II for Immunotherapy for cancer together
Key Topics
Details
Industry: Technology
biokine.comAI Visibility Breakdown
1
Structured Data
7
Content Structure
6
Entity Clarity
5
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Biokine Therapeutics.
Source & Attribution
Scored by Engagemii on June 26, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/biokine
Cite this score: Engagemii (2026). "AEO Score for Biokine Therapeutics." Retrieved from https://engagemii.com/aeo/brands/biokine
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform